Mu J, Wang Q, Dun W, et al. The effects of long-term menstrual pain on pain empathy in women with primary dysmenorrhea. Pain 2021;162:2051-9. doi: 10.1097/j.pain.0000000000002205.

Feng X, Wang X. Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: a network meta-analysis. Mol Pain 2018;14:1744806918770320. doi: 10.1177/1744806918770320.

Komada Y, Ikeda Y, Sato M, Kami A, Masuda C, Shibata S. Social jetlag and menstrual symptoms among female university students. Chronobiol Int 2019;36:258-264. doi: 10.1080/07420528.2018.1533561.

Samy A, Zaki SS, Metwally AA, et al. The effect of Zumba exercise on reducing menstrual pain in young women with primary dysmenorrhea: a randomized controlled trial. J Pediatr Adolesc Gynecol 2019;32:541-5. doi: 10.1016/j.jpag.2019.06.001.

Lamont JM, Wagner KM, Incorvati CG. The relationship of self-objectification and body shame to attitudes toward and willingness to use reusable menstrual products. Women's Reprod Health 2019;6:1-16. doi: 10.1080/23293691.2018.1556428.

Ozder A, Salduz Z. The prevalence of dysmenorrhea and its effects on female university students’ quality of life: what can we do in primary care. Int J Clin Exp Med 2020;13:6496-505.

Pramanik P, Pramanik P. Association of psychological distress with primary dysmenorrhea among adolescents living in West Bengal, India. Asian J Med Health 2023;21:92-101. DOI: 10.9734/AJMAH/2023/v21i8842.

Chehreh R, Sayemiri K, Shohani M, et al. Comparing the effect of herbal drugs and non-steroidal anti-inflammatory drugs on primary dysmenorrhea in Iran: a systematic review and meta-analysis. J Chem Health Risks 2021;11:41-53. DOI: 10.22034/jchr.2020.1882587.1061.

Tu CH, Lin CL, Yang ST, Shen WC, Chen YH. Hormonal contraceptive treatment may reduce the risk of fibromyalgia in women with dysmenorrhea: a cohort study. J Pers Med 2020;10:280. doi: 10.3390/jpm10040280.

Chen CX, Shieh C, Draucker CB, Carpenter JS. Reasons women do not seek health care for dysmenorrhea. J Clin Nurs 2018;27:e301-8. doi: 10.1111/jocn.13946.

Abubakar U, Zulkarnain AI, Samri F, et al. Use of complementary and alternative therapies for the treatment of dysmenorrhea among undergraduate pharmacy students in Malaysia: a cross sectional study. BMC Complement Med Ther 2020; 20:285. doi: 10.1186/s12906-020-03082-4.

Kossaï M, Penault-Llorca F. Role of hormones in common benign uterine lesions: endometrial polyps, leiomyomas, and adenomyosis. Adv Exp Med Biol 2020; 1242:37-58. doi: 10.1007/978-3-030-38474-6_3.

Kartal YA, Akyuz EY. The effect of diet on primary dysmenorrhea in university students: a randomized controlled clinical trial. Pak J Med Sci 2018; 34:1478-82. doi: 10.12669/pjms.346.16477.

Martire FG, Russo C, Selntigia A, et al. Early noninvasive diagnosis of endometriosis: dysmenorrhea and specific ultrasound findings are important indicators in young women. Fertil Steril 2023;119:455-64. doi: 10.1016/j.fertnstert.2022.12.004.

Omidvar S, Bakouei F, Amiri FN, Begum K. Primary dysmenorrhea and menstrual symptoms in Indian female students: prevalence, impact and management. Glob J Health Sci 2016;8:53632. doi: 10.5539/gjhs. v8n8p135.

Bakhsh H, Algenaimi E, Aldhuwayhi R, AboWadaan M. Prevalence of dysmenorrhea among reproductive age group in Saudi Women. BMC Womens Health 2022; 22:78. doi: 10.1186/s12905-022-01654-9.

Nie W, Xu P, Hao C, Chen Y, Yin Y, Wang L. Efficacy and safety of over-the-counter analgesics for primary dysmenorrhea: a network meta-analysis. Medicine (Baltimore) 2020;99: e19881. doi: 10.1097/MD.0000000000019881.

Quick F, Mohammad-Alizadeh-Charandabi S, Mirghafourvand M. Primary dysmenorrhea with and without premenstrual syndrome: variation in quality of life over menstrual phases. Qual Life Res 2019;28:99-107. doi: 10.1007/s11136-018-1999-9.

Habibi N, Huang MS, Gan WY, Zulida R, Safavi SM. Prevalence of primary dysmenorrhea and factors associated with its intensity among undergraduate students: a cross-sectional study. Pain Manag Nurs 2015;16:855-61. doi: 10.1016/j.pmn.2015.07.001.

Bavil DA, Dolatian M, Mahmoodi Z, Baghban AA. Comparison of lifestyles of young women with and without primary dysmenorrhea. Electron Physician 2016;8:2107-14. doi: 10.19082/2107.

Yoshino O, Takahashi N, Suzukamo Y. Menstrual symptoms, health-related quality of life, and work productivity in Japanese women with dysmenorrhea receiving different treatments: prospective observational study. Adv Ther 2022;39:2562-77. doi: 10.1007/s12325-022-02118-0.

Francavilla R, Petraroli M, Messina G, et al. Dysmenorrhea: epidemiology, causes and current state of the art for treatment. Clin Exp Obstet Gynecol 2023; 50:274. doi:10.31083/j.ceog5012274.

Koren G, Ornoy A. Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation. Pharmacogenomics 2018 ;19:1139-45. doi: 10.2217/pgs-2018-0076.

Wiest EF, Walsh-Wilcox MT, Walker MK. Omega-3 polyunsaturated fatty acids protect against cigarette smoke-induced oxidative stress and vascular dysfunction. Toxicol Sci 2017;156:300-10. doi: 10.1093/toxsci/kfw255. doi: 10.1093/toxsci/kfw255.

Wang YJ, Wang YZ, Yeh ML. A prospective comparison study of heart rate variability during menses in young women with dysmenorrhea. Biol Res Nurs 2016;18:465-72. doi: 10.1177/1099800416640875.

Clemenza S, Vannuccini S, Capezzuoli T, Meleca CI, Pampaloni F, Petraglia F. Is primary dysmenorrhea a precursor of future endometriosis development? Gynecol Endocrino 2021;37:287-93. doi: 10.1080/09513590.2021.1878134.

Li XH, Sun XX, Liang YL, et al. Effects of moxibustion at different times on prostaglandin and vasopressin levels in uterine tissues of rats with dysmenorrhea due to cold-dampness retention. J Acupunct Tuina Sci 2017;15:250-6. doi: 10.1007/s11726-017-1009-8.

Kor E, Mostafavi SR, Mazhin ZA, et al. Relationship between the severity of endometriosis symptoms (dyspareunia, dysmenorrhea and chronic pelvic pain) and the spread of the disease on ultrasound. BMC Res Notes 2020;13:1-8. doi: 10.1186/s13104-020-05388-5.

Krzemińska P, Kołodziej J, Biniewicz A. Primary and secondary dysmenorrhea: symptoms, risk factors, diagnosis, and treatment–review. Quality Sport 2024; 21:53346. doi: 10.12775/QS.2024.21.53346.

Lee JY, Kim JH, Lee IS. A literature review on syndrome differentiation of dysmenorrhea. J Korean Obstet Gynecol 2019;32:48-72. DOI:10.15204/JKOBGY.2019.32.1.048.

Rao KA, Chandra S, Kasture PN. Role of prostaglandins in pathogenesis of dysmenorrhea and place of mefenamic acid and dicyclomine in its management. Indian J Clin Pract 2022;32:27-34.

Smith RP. The role of prostaglandins in dysmenorrhea and menorrhagia. In: Dysmenorrhea and menorrhagia. Cham: Springer; 2018. pp. 75-888. doi:10.1007/978-3-319-71964-1_6.

Borzutzky C, Jaffray J. Diagnosis and management of heavy menstrual bleeding and bleeding disorders in adolescents. JAMA Pediatrics 2020;174:186-94. doi:10.1001/jamapediatrics.2019.5040

Fajrin I, Alam G, Usman AN. Prostaglandin level of primary dysmenorrhea pain sufferers. Enfermería Clínica 2020;30:5-9. doi: 10.1016/j.enfcli.2019.07.016.

Payne LA, Seidman LC, Sim MS, Rapkin AJ, Naliboff BD, Zeltzer LK. Experimental evaluation of central pain processes in young women with primary dysmenorrhea. Pain 2019;160:1421-30. doi: 10.1097/j.pain.0000000000001516.

Kovács Z, Hegyi G, Szőke H. The effect of exercise on pulsatility index of uterine arteries and pain in primary dysmenorrhea. J Clin Med 2023;12:7021. doi:10.3390/jcm12227021.

Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Wsol A. The role of oxytocin and vasopressin in the pathophysiology of heart failure in pregnancy and in fetal and neonatal life. Am J Physiol Heart Circ Physiol 2020;318:H639-51. doi:10.1152/ajpheart.00484.2019.

Liu Y, Tang WJ, Wang YQ, Tang B. Effects of electroacupuncture on uterine prostaglandin F2α, cyclooxygenase 2 and nuclear factor κB in rats with primary dysmenorrhea. J Acupunct Tuina Sci 2020;18:418-24. doi:10.1007/s11726-020-1209-5

Li S, Qi J, Tao Y, et al. Elevated levels of arachidonic acid metabolites in follicular fluid of PCOS patients. Reproduction 2020;159:159-69. doi:10.1530/REP-19-0136.

Mohammadi MM, Mirjalili R, Faraji A. The impact of omega-3 polyunsaturated fatty acids on primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2022;78:721-31. doi:10.1007/s00228-021-03263-1.

Chang L, Tang X, Lu H, et al. Role of adenosine monophosphate deaminase during fatty acid accumulation in oleaginous fungus Mortierella alpina. J Agric Food Chem 2019;5:67:9551-9. doi: 10.1021/acs.jafc.9b03603

Garvin SE, Kyathanahalli C, Soha S, Condon JC, Jeyasuria P. Preimplantation apoptotic endometrial caspase-3-mediated phospholipase A2 activation: a potential component in programming uterine receptivity. F S Sci 2023;4:141-50. doi: 10.1016/j.xfss.2022.12.003.

Liang W, Zhao Y, Quan G, et al. Localization and expression of phospholipase A2 and polyunsaturated fatty acid profile in the testis tissues of Hu sheep. Anim Reprod Sci 2024;260:10738. doi: 10.1016/j.anireprosci.2023.107381.

Barcikowska Z, Grzybowska ME, Wąż P, et al. Effect of manual therapy compared to ibuprofen on primary dysmenorrhea in young women-concentration assessment of C-reactive protein, vascular endothelial growth factor, prostaglandins and sex hormones. J Clin Med 2022;11:2686. doi:10.3390/jcm11102686.

Kanchibhotla D, Subramanian S, Singh D. Management of dysmenorrhea through yoga: a narrative review. Front Pain Res 2023;4:1107669. doi:10.3389/fpain.2023.1107669.

Chen Z, Peng Y, Qiang X, et al. Oral traditional Chinese patent medicines combined with non-steroidal anti-inflammatory drugs for primary dysmenorrhea: a protocol for Bayesian network meta-analysis and systematic review. PloS ONE 2022;17:e0276129. doi: 10.1371/journal.pone.0276129.

Rodriguez MB, Lethaby A, Farquhar C. Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2019;9: CD000400. doi: 10.1002/14651858.CD000400.pub4.

Aqwaan HW. The role of certain specific hormonal treatments in estrus synchronization of ewes: a mini review. Kufa J Vet Med Sci 2023;14:27-37. doi:10.36326/kjvs/2023/v14i110923.

Ruan KH, Lu R. Latest advancements in the study of the relationship between NSAIDs and three prostaglandin E2 synthases. Future Med Chem 2023;15:1549-52. doi:10.4155/fmc-2023-0172.

DÖNMEZ S, ŞENER A, ERDEM AB, ÇETİN Ç, KURTOĞLU ÇELİK G. Analgesic efficacy of ibuprofen in dysmenorrhea. Bezmiâlem Sci 2023;11:163-9. doi: 10.14235/bas.galenos.2022.18480.

Sohail R, Mathew M, Patel KK, et al. Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review. Cureus 2023;15:e37080. doi: 10.7759/cureus.37080.

Oladosu FA, Tu FF, Hellman KM. Nonsteroidal anti-inflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. Am J Obstet Gynecol 2018;218:390-400. doi: 10.1016/j.ajog.2017.08.108.

Kashefi F, Khajehei M, Tabatabaeichehr M, Alavinia M, Asili J. Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial. Pain Manage Nurs 2014;15:826-33. doi: 10.1016/j.pmn.2013.09.001.

Özgül S, Üzelpasaci E, Orhan C, Baran E, Beksaç MS, Akbayrak T. Short-term effects of connective tissue manipulation in women with primary dysmenorrhea: a randomized controlled trial. Complement Ther Clin Pract 2018;33:1-6. doi: 10.1016/j.ctcp.2018.07.007.

Chen CX, Shieh C, Draucker CB, Carpenter JS. Reasons women do not seek health care for dysmenorrhea. J Clin Nurs 2018;27:e301-8. doi:10.1111/jocn.13946.

Oladosu FA, Tu FF, Hellman KM. Nonsteroidal anti-inflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment. Am J Obstet Gynecol 2018;218:390-400. doi:10.1016/j.ajog.2017.08.108.

Machado AFP, Perracini MR, Rampazo ÉP, Driusso P, Liebano RE. Effects of thermotherapy and transcutaneous electrical nerve stimulation on patients with primary dysmenorrhea: a randomized, placebo-controlled, double-blind clinical trial. Complement Ther Med 2019;47:102188. doi:10.1016/j.ctim.2019.08.022.

Muthulakshmi K, Monesh D, Moses S, et al. Connective tissue mobilization vs. combination of taping with pelvic tilt on primary dysmenorrhea. Int J Life Sci Pharma Res 2023;13:L349-56. doi:10.22376/ijlpr.2023.13.5.L349-L356.

Sergun VP, Evgenia B, Burkova VN, Poznyakovsky VM, Danko NN, Tokhiriyon B. Treatment of menstruation disorders at puberty: a plant-based dietary supplement efficacy and safety. J Biochem Technol 2023;14:13-7. doi:10.51847/r9vJrE0mHw.

Mohammadi MM, Mirjalili R, Faraji A. The impact of omega-3 polyunsaturated fatty acids on primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2022;78:721-31. doi:10.1007/s00228-021-03263-1.

Snipe RM, Brelis B, Kappas C, et al. Omega‐3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhea pain: systematic literature review and meta‐analysis. Nutr Diet 2024;81:94-106. doi: 10.1111/1747-0080.12835.

Barcikowska Z, Rajkowska-Labon E, Grzybowska ME, Hansdorfer-Korzon R, Zorena K. Inflammatory markers in dysmenorrhea and therapeutic options. Int J Environ Res Public Health 2020;17:1191. doi:10.3390/ijerph17041191

Osmanlıoğlu Ş, Sanlier N. The relationship between endometriosis and diet. Hum Fert 2023;26:649-64. doi:10.1080/14647273.2021.1995900.

Kovács Z, Atombosiye E, Hegyi G, Szőke H. The effect of Aviva exercise intervention on pain level and body awareness in women with primary dysmenorrhea. Medicina 2024;60:184. doi:10.3390/medicina60010184.

Farrah AM, Halim B, Kaban Y. Effectiveness of zinc supplementation in treating dysmenorrhea. Bali Med J 2017 ;6:34-7. doi:10.15562/bmj.v6i1.380.

Zhang F, Sun M, Han S, et al. Acupuncture for primary dysmenorrhea: an overview of systematic reviews. Evid Based Complement Alternat Med 2018;2018. doi:10.1155/2018/8791538.

Kushwah B, Kushwah DS, Pandey A. A prospective, double blind randomised controlled trial on efficacy of laparoscopic uterosacral nerve ablation as an alternative of pharmacotherapy in treatment of chronic pelvic pain. Int J Basic Clin Pharmacol 2018;7:473. doi: 10.18203/2319-2003.ijbcp20180660.

Laguerre MD, Arkerson BJ, Robinson MA, Moawad NS. Outcomes of laparoscopic management of chronic pelvic pain and endometriosis. J Obstet Gynaecol 2022;42:146-52. doi:10.1080/01443615.2021.1882967.

Whitaker LH, Doust A, Stephen J, et al. Laparoscopic treatment of isolated superficial peritoneal endometriosis for managing chronic pelvic pain in women: study protocol for a randomised controlled feasibility trial (ESPriT1). Pilot Feasibility Stud 2021;7:1-8. doi:10.1186/s40814-020-00740-9.

Api M, Boza A, Ceyhan M, Kaygusuz E, Yavuz H, Api O. The efficacy of laparoscopic presacral neurectomy in dysmenorrhea: is it related to the amount of excised neural tissue? Turk J Obstet Gynecol 2017;14:238-42. DOI: 10.4274/tjod.56588.

Shim S, Park KM, Chung YJ, Kim MR. Updates on therapeutic alternatives for genitourinary syndrome of menopause: hormonal and non-hormonal managements. J Menopausal Med 2021;27:1. doi:10.6118/jmm.20034 .

Bassuk SS, Manson JE. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes. Ann Epidemiol 2015;25:193-200. doi: 10.1016/j.annepidem.2014.11.004.

Karout S, Soubra L, Rahme D, Karout L, Khojah HMJ, Itani R. Prevalence, risk factors, and management practices of primary dysmenorrhea among young females. BMC Women's Health 2021;21:1-4. doi:10.1186/s12905-021-01532-w.

Del Savio CM, De Fata R, Facchinetti F, Grandi G. Drospirenone 4 mg-only pill (DOP) in 24+ 4 regimen: a new option for oral contraception. Expert Rev Clin Pharmacol 2020;13:685-94. doi:10.1080/17512433.2020.1783247.

Zorbas KA, Economopoulos KP, Vlahos NF. Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review. Arch Gynecol Obstet 2015;292:37-43. doi:10.1007/s00404-015-3641-1

Burnett M, Lemyre M. No. 345-primary dysmenorrhea consensus guideline. J Obstet Gynecol Canada 2017;39:585-95. doi: 10.1016/j.jogc.2016.12.023.

Zhang Z, Xu L, Zhang Z, Ding H, Rayburn ER, Li H. The need for contraception in patients taking prescription drugs: a review of FDA warning labels, duration of effects, and mechanisms of action. Expert Opin Drug Saf 2018;17:1171-83. doi: 10.1080/14740338.2018.1544617.

Taylor HS, Soliman AM, Johns B, Pokrzywinski RM, Snabes M, Coyne KS. Health-related quality of life improvements in patients with endometriosis treated with Elagolix. Obstet Gynecol 2020;136:501-9. doi:10.1097/AOG.0000000000003917.

Itani R, Soubra L, Karout S, Rahme D, Karout L, Khojah HMJ. Primary dysmenorrhea: pathophysiology, diagnosis, and treatment updates. Korean J Family Med 2022;43:101. doi:10.4082/kjfm.21.0103 .

Pereira A, Herrero-Trujillano M, Vaquero G, et al. Clinical management of chronic pelvic pain in endometriosis unresponsive to conventional therapy. J Person Med 2022;12:101. doi:10.3390/jpm12010101.

Skliutė G, Baušytė R, Borutinskaitė V, et al. Menstrual blood-derived endometrial stem cells' impact for the treatment perspective of female infertility. Int J Mol Sci 2021;22:6774. doi:10.3390/ijms22136774.

Sabale PM, Sabale VP, Potey LC. Aromatase and aromatase inhibitors in breast cancer treatment. J Curr Pharma Res 2018;9:2636-55. doi: 10.33786/JCPR. 2018.v09i01.008.